<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Arterial thrombotic events, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> with <z:hpo ids='HP_0001981'>schistocytes</z:hpo> may be encountered in the setting of both thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="1" ids="18284">TTP</z:chebi>) and <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>We report 2 cases of <z:chebi fb="1" ids="18284">TTP</z:chebi> occurring in patients with definite primary APS </plain></SENT>
<SENT sid="2" pm="."><plain>We also describe the results of tests for ADAMTS-13 activity in 20 consecutive patients with primary APS, as well as tests for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in 26 patients who had <z:chebi fb="1" ids="18284">TTP</z:chebi>, severe ADAMTS-13 deficiency, and ADAMTS-13-inhibiting antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>In both of the patients with primary APS and <z:chebi fb="1" ids="18284">TTP</z:chebi>, ADAMTS-13 activity was undetectable, and ADAMTS-13-inhibiting antibodies were present </plain></SENT>
<SENT sid="4" pm="."><plain>None of the 26 patients with <z:chebi fb="1" ids="18284">TTP</z:chebi> and severe ADAMTS-13 deficiency was positive for the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>One of these patients had a low level of anticardiolipin antibodies (22 IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi> units) </plain></SENT>
<SENT sid="6" pm="."><plain>In the 20 patients with primary APS, mean ADAMTS-13 activity was 116% (range 44-250%), and no severe deficiency (&lt; 5%) was observed </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest that primary APS must be added to the list of <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> that can be complicated by <z:chebi fb="1" ids="18284">TTP</z:chebi> </plain></SENT>
</text></document>